Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
accreted, accretion, arrest, atherosclerotic, beta, bid, broader, broken, brokerage, calendar, chest, composed, composite, compromising, consecutive, cured, deficiency, delisting, diabetic, diarrhea, disability, disclosed, drop, dysfunction, eat, elucidating, energy, evidenced, evolution, extinguished, extinguishment, eye, fallen, fuel, GAAP, gland, glucose, glycemic, growth, hand, hard, hearing, hormone, infrequently, inLiquidity, instrument, insulin, intent, leave, Lilly, listed, listing, liver, macrovascular, mg, microvascular, nephropathy, neuropathy, newly, notification, notified, opportunity, opposed, organizational, predefined, qualification, refinance, Refinanced, regain, reinitiate, repay, repayment, resistance, Resourcesabove, restructure, restructuring, resuscitated, retinopathy, semiannually, serve, source, stimulate, stimulating, stomach, streamline, streamlining, subgroup, sugar, Takeda, Title, transient, twelve, underutilized, unrecognized, workforce
Removed:
accelerate, adjacent, advisory, agreeable, aimed, air, airway, alert, allergy, analyzed, angioplasty, anniversary, announcement, apparent, applicability, approach, area, articular, Asthmatic, attached, attestation, attractive, bacteria, barrier, biochemical, biomarker, bone, Brigham, bronchial, Canadian, cardiology, Carolina, cartilage, Chairman, CHD, children, cold, concentrated, confirmation, construed, contacted, continuously, counsel, created, curtail, cyclosporin, debilitating, dedication, degradation, Department, difficulty, digest, diligent, direct, disadvantage, discovering, disorder, division, donated, donor, education, elderly, elevated, Enbrel, entering, episodic, Erwin, etanercept, ethnic, evaluate, examined, exceeded, expedite, expression, factor, fashion, flexibility, flow, fluid, formal, functioning, Gary, Gelfand, generation, highlighted, Hospital, ibuprofen, identical, IIb, immune, immunologically, immunosuppressive, improperly, improving, incompatibility, incompatible, individual, informal, inhaled, Inhibitex, injected, input, inquiry, insolvency, intravascular, introduction, invade, investigation, Johnson, knowledge, latch, leveraged, Libby, limiting, lining, loan, losing, luminal, Medicine, membrane, methotrexate, migration, Modern, modifying, modulation, movement, mutually, myeloperoxidase, NASD, newer, North, numerically, occasional, opening, originally, outnumber, ozone, percent, Peter, Pfizer, planning, plaque, powerful, preclinically, President, principally, procure, Professor, proliferation, proper, protectant, rapamycin, rapidly, recipient, Registry, regression, regular, reject, relieving, relinquish, removed, renew, requested, rest, revert, rheumatoid, robust, rotating, roughly, run, salary, School, shape, shortage, showed, significance, Silicon, size, slowly, stepwise, stopping, sublicensee, sublicensing, subsegment, surgically, symptomatic, synovium, synthesizing, termed, tolerated, toxic, trading, traditional, transplantation, transplanted, triglyceride, tumor, ultrasound, uncured, unmet, Valley, vesting, violated, violation, volume, voluntarily, vulnerability, warmth, world
Filing tables
Filing exhibits
- 10-K Annual report
- 10.23 EX-10.23 Employment Agreement/russell M. Medford
- 10.24 EX-10.24 Employment Agreement/mark P. Colonnese
- 10.25 EX-10.25 Employment Agreement/w. Charles Montgomery
- 10.26 EX-10.26 Employment Agreement/joseph M. Gaynor, JR.
- 23.01 EX-23.01 Consent of Ernst & Young LLP
- 24.01 EX-24.01 Powers of Attorney
- 31.1 EX-31.1 Section 302 Certification of the CEO
- 31.2 EX-31.2 Section 302 Certification of the CFO
- 32 EX-32 Section 906 Certifications of the CEO and CFO
Related press release
AGIX similar filings
Filing view
External links
Exhibit 23.01
Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-3 Nos. 333-110160, 333-101174 and 333-123895 and Form S-8 Nos. 333-114953, 333-69552, and 333-55886) of AtheroGenics, Inc., of our reports dated February 29, 2008, with respect to the financial statements of AtheroGenics, Inc., and the effectiveness of internal control over financial reporting of AtheroGenics, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2007.
/s/ Ernst & Young LLP
Atlanta, Georgia
February 29, 2008
February 29, 2008